Cargando…

Heterozygous expression of the Alzheimer’s disease-protective PLCγ2 P522R variant enhances Aβ clearance while preserving synapses

BACKGROUND: A rare coding variant, P522R, in the phospholipase C gamma 2 (PLCG2) gene has been identified as protective against late-onset Alzheimer’s disease (AD), but the mechanism is unknown. PLCG2 is exclusively expressed in microglia within the central nervous system, and altered microglial fun...

Descripción completa

Detalles Bibliográficos
Autores principales: Solomon, Shiden, Sampathkumar, Nirmal Kumar, Carre, Ivo, Mondal, Mrityunjoy, Chennell, George, Vernon, Anthony C., Ruepp, Marc-David, Mitchell, Jacqueline C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329165/
https://www.ncbi.nlm.nih.gov/pubmed/35895133
http://dx.doi.org/10.1007/s00018-022-04473-1
_version_ 1784757879246422016
author Solomon, Shiden
Sampathkumar, Nirmal Kumar
Carre, Ivo
Mondal, Mrityunjoy
Chennell, George
Vernon, Anthony C.
Ruepp, Marc-David
Mitchell, Jacqueline C
author_facet Solomon, Shiden
Sampathkumar, Nirmal Kumar
Carre, Ivo
Mondal, Mrityunjoy
Chennell, George
Vernon, Anthony C.
Ruepp, Marc-David
Mitchell, Jacqueline C
author_sort Solomon, Shiden
collection PubMed
description BACKGROUND: A rare coding variant, P522R, in the phospholipase C gamma 2 (PLCG2) gene has been identified as protective against late-onset Alzheimer’s disease (AD), but the mechanism is unknown. PLCG2 is exclusively expressed in microglia within the central nervous system, and altered microglial function has been implicated in the progression of AD. METHODS: Healthy control hiPSCs were CRISPR edited to generate cells heterozygous and homozygous for the PLCG2(P522R) variant. Microglia derived from these hiPSC’s were used to investigate the impact of PLCγ2(P522R) on disease relevant processes, specifically microglial capacity to take up amyloid beta (Aβ) and synapses. Targeted qPCR assessment was conducted to explore expression changes in core AD linked and microglial genes, and mitochondrial function was assessed using an Agilent Seahorse assay. RESULTS: Heterozygous expression of the P522R variant resulted in increased microglial clearance of Aβ, while preserving synapses. This was associated with the upregulation of a number of genes, including the anti-inflammatory cytokine Il-10, and the synapse-linked CX3CR1, as well as alterations in mitochondrial function, and increased cellular motility. The protective capacity of PLCγ2(P522R) appeared crucially dependent on (gene) ‘dose’, as cells homozygous for the variant showed reduced synapse preservation, and a differential gene expression profile relative to heterozygous cells. CONCLUSION: These findings suggest that PLCγ2(P522R) may result in increased surveillance by microglia, and prime them towards an anti-inflammatory state, with an increased capacity to respond to increasing energy demands, but highlights the delicate balance of this system, with increasing PLCγ2(P522R) ‘dose’ resulting in reduced beneficial impacts. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00018-022-04473-1.
format Online
Article
Text
id pubmed-9329165
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-93291652022-07-29 Heterozygous expression of the Alzheimer’s disease-protective PLCγ2 P522R variant enhances Aβ clearance while preserving synapses Solomon, Shiden Sampathkumar, Nirmal Kumar Carre, Ivo Mondal, Mrityunjoy Chennell, George Vernon, Anthony C. Ruepp, Marc-David Mitchell, Jacqueline C Cell Mol Life Sci Original Article BACKGROUND: A rare coding variant, P522R, in the phospholipase C gamma 2 (PLCG2) gene has been identified as protective against late-onset Alzheimer’s disease (AD), but the mechanism is unknown. PLCG2 is exclusively expressed in microglia within the central nervous system, and altered microglial function has been implicated in the progression of AD. METHODS: Healthy control hiPSCs were CRISPR edited to generate cells heterozygous and homozygous for the PLCG2(P522R) variant. Microglia derived from these hiPSC’s were used to investigate the impact of PLCγ2(P522R) on disease relevant processes, specifically microglial capacity to take up amyloid beta (Aβ) and synapses. Targeted qPCR assessment was conducted to explore expression changes in core AD linked and microglial genes, and mitochondrial function was assessed using an Agilent Seahorse assay. RESULTS: Heterozygous expression of the P522R variant resulted in increased microglial clearance of Aβ, while preserving synapses. This was associated with the upregulation of a number of genes, including the anti-inflammatory cytokine Il-10, and the synapse-linked CX3CR1, as well as alterations in mitochondrial function, and increased cellular motility. The protective capacity of PLCγ2(P522R) appeared crucially dependent on (gene) ‘dose’, as cells homozygous for the variant showed reduced synapse preservation, and a differential gene expression profile relative to heterozygous cells. CONCLUSION: These findings suggest that PLCγ2(P522R) may result in increased surveillance by microglia, and prime them towards an anti-inflammatory state, with an increased capacity to respond to increasing energy demands, but highlights the delicate balance of this system, with increasing PLCγ2(P522R) ‘dose’ resulting in reduced beneficial impacts. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00018-022-04473-1. Springer International Publishing 2022-07-27 2022 /pmc/articles/PMC9329165/ /pubmed/35895133 http://dx.doi.org/10.1007/s00018-022-04473-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Solomon, Shiden
Sampathkumar, Nirmal Kumar
Carre, Ivo
Mondal, Mrityunjoy
Chennell, George
Vernon, Anthony C.
Ruepp, Marc-David
Mitchell, Jacqueline C
Heterozygous expression of the Alzheimer’s disease-protective PLCγ2 P522R variant enhances Aβ clearance while preserving synapses
title Heterozygous expression of the Alzheimer’s disease-protective PLCγ2 P522R variant enhances Aβ clearance while preserving synapses
title_full Heterozygous expression of the Alzheimer’s disease-protective PLCγ2 P522R variant enhances Aβ clearance while preserving synapses
title_fullStr Heterozygous expression of the Alzheimer’s disease-protective PLCγ2 P522R variant enhances Aβ clearance while preserving synapses
title_full_unstemmed Heterozygous expression of the Alzheimer’s disease-protective PLCγ2 P522R variant enhances Aβ clearance while preserving synapses
title_short Heterozygous expression of the Alzheimer’s disease-protective PLCγ2 P522R variant enhances Aβ clearance while preserving synapses
title_sort heterozygous expression of the alzheimer’s disease-protective plcγ2 p522r variant enhances aβ clearance while preserving synapses
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329165/
https://www.ncbi.nlm.nih.gov/pubmed/35895133
http://dx.doi.org/10.1007/s00018-022-04473-1
work_keys_str_mv AT solomonshiden heterozygousexpressionofthealzheimersdiseaseprotectiveplcg2p522rvariantenhancesabclearancewhilepreservingsynapses
AT sampathkumarnirmalkumar heterozygousexpressionofthealzheimersdiseaseprotectiveplcg2p522rvariantenhancesabclearancewhilepreservingsynapses
AT carreivo heterozygousexpressionofthealzheimersdiseaseprotectiveplcg2p522rvariantenhancesabclearancewhilepreservingsynapses
AT mondalmrityunjoy heterozygousexpressionofthealzheimersdiseaseprotectiveplcg2p522rvariantenhancesabclearancewhilepreservingsynapses
AT chennellgeorge heterozygousexpressionofthealzheimersdiseaseprotectiveplcg2p522rvariantenhancesabclearancewhilepreservingsynapses
AT vernonanthonyc heterozygousexpressionofthealzheimersdiseaseprotectiveplcg2p522rvariantenhancesabclearancewhilepreservingsynapses
AT rueppmarcdavid heterozygousexpressionofthealzheimersdiseaseprotectiveplcg2p522rvariantenhancesabclearancewhilepreservingsynapses
AT mitchelljacquelinec heterozygousexpressionofthealzheimersdiseaseprotectiveplcg2p522rvariantenhancesabclearancewhilepreservingsynapses